Comparative Genomics and Proteomics in Drug Discovery: Vol 58, 1st Edition (Paperback) book cover

Comparative Genomics and Proteomics in Drug Discovery

Vol 58, 1st Edition

Edited by John Parrington, Kevin Coward

Taylor & Francis

164 pages

Purchasing Options:$ = USD
Paperback: 9780367389734
pub: 2019-08-30
SAVE ~$14.99
Available for pre-order
Hardback: 9780415396530
pub: 2006-11-09
SAVE ~$57.00
eBook (VitalSource) : 9780203967294
pub: 2018-12-07
from $28.98

FREE Standard Shipping!


Comparative Genomics and Proteomics in Drug Discovery gives an overview of how emerging genomic and proteomic technologies are making significant contributions to global drug discovery programs, and in particular the key role that comparative genomics and proteomics play within this strategy. Each chapter is written by respected authorities, with hands-on experience, from both academic and pharmaceutical backgrounds.

Table of Contents

1. Comparative Genomics and Drug Discovery in Trypanosomatids 2. The Practical Implications of Comparative Kinetoplastid Genomics 3. The Relevance of Host Genes in Malaria 4. Nicotinic Acetylcholine Receptors as Drug/Chemical Targets, Contributions from Comparative Genomics, Forward and Reverse Genetics 5. Discovery of Novel Sodium Channel Inhibitors - A Gene Family-Based Approach 6. 'Omics' in Translational Medicine : Are They Lost in Translation? 7. Drug-Target Discovery In Silico : Using the Web to Identify Novel Molecular Targets for Drug Action

About the Editors

John Parrington and Kevin Coward, Department of Pharmacology, University of Oxford, UK.

Subject Categories

BISAC Subject Codes/Headings:
SCIENCE / General
SCIENCE / Life Sciences / Biology / General
SCIENCE / Life Sciences / Genetics & Genomics
SCIENCE / Life Sciences / Biology / Molecular Biology
SCIENCE / Life Sciences / General